Your browser doesn't support javascript.
loading
Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial.
Hamy, Anne-Sophie; Tury, Sandrine; Wang, Xiaofei; Gao, Junheng; Pierga, Jean-Yves; Giacchetti, Sylvie; Brain, Etienne; Pistilli, Barbara; Marty, Michel; Espié, Marc; Benchimol, Gabriel; Laas, Enora; Laé, Marick; Asselain, Bernard; Aouchiche, Brice; Edelman, Martin; Reyal, Fabien.
Afiliação
  • Hamy AS; 1 Institut Curie, Université Paris Descartes, Paris, France.
  • Tury S; 1 Institut Curie, Université Paris Descartes, Paris, France.
  • Wang X; 2 Alliance Statistics and Data Center, Durham, NC.
  • Gao J; 2 Alliance Statistics and Data Center, Durham, NC.
  • Pierga JY; 1 Institut Curie, Université Paris Descartes, Paris, France.
  • Giacchetti S; 3 Hôpital Saint Louis (APHP), Université Paris Diderot, Paris, France.
  • Brain E; 1 Institut Curie, Université Paris Descartes, Paris, France.
  • Pistilli B; 4 Gustave Roussy, Villejuif, France.
  • Marty M; 3 Hôpital Saint Louis (APHP), Université Paris Diderot, Paris, France.
  • Espié M; 3 Hôpital Saint Louis (APHP), Université Paris Diderot, Paris, France.
  • Benchimol G; 1 Institut Curie, Université Paris Descartes, Paris, France.
  • Laas E; 1 Institut Curie, Université Paris Descartes, Paris, France.
  • Laé M; 1 Institut Curie, Université Paris Descartes, Paris, France.
  • Asselain B; 1 Institut Curie, Université Paris Descartes, Paris, France.
  • Aouchiche B; 1 Institut Curie, Université Paris Descartes, Paris, France.
  • Edelman M; 5 Fox Chase Cancer Center, Philadelphia, PA.
  • Reyal F; 1 Institut Curie, Université Paris Descartes, Paris, France.
J Clin Oncol ; 37(8): 624-635, 2019 03 10.
Article em En | MEDLINE | ID: mdl-30702971
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores de Estrogênio / Biomarcadores Tumorais / Terapia Neoadjuvante / Ciclo-Oxigenase 2 / Inibidores de Ciclo-Oxigenase 2 / Celecoxib Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores de Estrogênio / Biomarcadores Tumorais / Terapia Neoadjuvante / Ciclo-Oxigenase 2 / Inibidores de Ciclo-Oxigenase 2 / Celecoxib Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article